Levetiracetam versus Phenobarbitone as First Line Antiepileptic Drug in Management of Neonatal Seizures: A Retrospective Cohort Study
Introduction: Neonatal seizures require urgent intervention, yet the optimal first-line treatment remains a subject of ongoing debate. While Phenobarbitone (PB) remains the traditional standard of care, its use is increasingly scrutinised due to adverse effects like respiratory depression and potential neurotoxicity in...